Cargando…
Systemic Treatment of Metastatic Conjunctival Melanoma
Conjunctival melanoma (CM) is an exceptionally rare tumor, with a propensity for local and distant recurrence, with the lungs, skin, liver, and brain being the most common sites of metastasis. Recent progress in systemic treatments, with checkpoint inhibitors and targeted therapies blocking BRAF and...
Autores principales: | Pinto Torres, Simão, André, Teresa, Gouveia, Emanuel, Costa, Lívio, Passos, Maria José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682064/ https://www.ncbi.nlm.nih.gov/pubmed/29214089 http://dx.doi.org/10.1155/2017/4623964 |
Ejemplares similares
-
Conjunctival melanoma following cornea transplant from a cancer donor: A case report
por: Kwitko, Sergio, et al.
Publicado: (2023) -
Tarsoconjunctival flap for scleromalacia related to treatments for conjunctival melanoma
por: Finger, Paul T., et al.
Publicado: (2023) -
Amelanotic conjunctival melanoma in a child
por: Vishnevskia-Dai, Vicktoria, et al.
Publicado: (2022) -
Conjunctival Melanoma: A Case Presentation
por: Montazer, Fatemeh, et al.
Publicado: (2023) -
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)